DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
1LBC_A_CYZA330 |
1lbc |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMINE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
12 |
ILE C 92LYS A 104PRO A 105MET A 107SER A 108SER C 217LYS C 218LEU A 239SER A 242LEU A 247ASP A 248LYS A 251 |
CYZ A 330
|
1LBC_B_CYZB329 |
1lbc |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMINE RECEPTOR 2 |
no annotation |
9 |
LYS B 104PRO B 105MET B 107SER B 108LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
CYZ B 329
|
1LBC_C_CYZC331 |
1lbc |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMINE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
12 |
ILE A 92LYS C 104PRO C 105MET C 107SER C 108SER A 217LYS A 218LEU C 239SER C 242LEU C 247ASP C 248LYS C 251 |
CYZ C 331
|
3H6T_A_CYZA265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
11 |
ILE C 92LYS A 104PRO A 105MET A 107SER A 108SER C 217LYS C 218LEU A 239SER A 242LEU A 247LYS A 251 |
CYZ A 265
|
3H6T_B_CYZB265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
no annotation |
9 |
LYS B 104PRO B 105MET B 107SER B 108LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
CYZ B 265
|
3H6T_C_CYZC265 |
3h6t |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
11 |
ILE A 92LYS C 104PRO C 105MET C 107SER C 108SER A 217LYS A 218LEU C 239SER C 242LEU C 247LYS C 251 |
CYZ C 265
|
3TKD_A_CYZA266 |
3tkd |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
14 |
ILE B 92LYS A 104PRO A 105PRO B 105MET A 107SER A 108SER B 217LYS B 218GLY B 219LEU A 239SER A 242LEU A 247ASP A 248LYS A 251 |
CYZ A 266
|
3TKD_B_CYZB267 |
3tkd |
CYZ DB00606(Cyclothiazide) |
Rattus norvegicus |
GLUTAMATE RECEPTOR 2 |
PF10613(Lig_chan-Glu_bd)no annotation |
14 |
ILE A 92LYS B 104PRO A 105PRO B 105MET B 107SER B 108SER A 217LYS A 218GLY A 219LEU B 239SER B 242LEU B 247ASP B 248LYS B 251 |
CYZ B 267
|
5WEO_A_CYZA1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE D 481PRO A 494PRO D 494MET A 496SER A 497SER D 497SER D 729GLY D 731ASP A 760LYS A 763 |
CYZ A1302
|
5WEO_B_CYZB1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
ILE C 481PRO C 494PRO B 494MET B 496SER B 497SER C 729GLY C 731ASP B 760LYS B 763 |
CYZ B1302
|
5WEO_C_CYZC1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
PRO C 494PRO B 494MET C 496SER B 497SER C 497SER B 729GLY B 731ASP C 760LYS C 763 |
CYZ C1302
|
5WEO_D_CYZD1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
9 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729GLY A 731ASP D 760LYS D 763 |
CYZ D1302
|
6DLZ_A_CYZA1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DLZ_B_CYZB1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DLZ_C_CYZC1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DLZ_D_CYZD1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM0_A_CYZA1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM0_B_CYZB1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729GLY C 731LEU B 751LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM0_C_CYZC1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM0_D_CYZD1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
PRO A 494MET D 496SER D 497SER A 729GLY A 731LEU D 751LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM1_A_CYZA1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM1_B_CYZB1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM1_C_CYZC1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM1_D_CYZD1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM2_A_CYZA1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM2_B_CYZB1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM2_C_CYZC1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM2_D_CYZD1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE A 481PRO A 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|